Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

This Energy Company’s Plans to Improve its Market Position

Back in August , Stockhouse Editorial sat down with Corey Dias – Chief Executive Officer of uranium and vanadium development company Anfield Energy Inc. (AEC) ( TSX-V.AEC , OTCQB: ANLDF , Forum ) – to talk about Anfield’s unique story, its acquisition o...
Dave Jackson | November 19, 2020 |

RIVERSIDE RESOURCES | BHP $2,000,000 Strategic Funding Update 5 Copper Projects

In this exclusive interview with Dr. John-Mark Staude of Riverside Resources provides a corporate update on the second year of strategic funding with BHP on 5 copper projects located in Sonora, Mexico,. The funding provides Riverside Resources...
Maurice Jackson | June 22, 2020 |

Prospera Energy plots success with proven reserves, M&A plans

The following is a transcription of the above video, and The Market Online has edited it for clarity . Prospera Energy Inc. (TSXV:PEI) is a Western Canadian resource company specializing in development and production of crude oil and natural gas. Prospera is primar...
Coreena Robertson | March 27, 2024 |

Fandom Sports Set to Launch NFT Marketplace Including Gamification & Rewards

THE PLATFORM PLANS TO REWARD FAN ENGAGEMENT WITH UTILITY AND UNIQUE CUSTOM NFTS Fandom Sports Media Corporation ( CSE: FDM , Forum ) , a Vancouver-based gaming and entertainment company, is all set to launch its all-ages gamification platform that will reward fan engageme...
Chris Thompson | April 5, 2022 |

F Disrespectful Fiduciary Responsibility

Concerned under the existential dread that "The robots could take over" and take control of the job of writer as easily as they did to that of the cashier or comedian, I attempted to create an article via an AI algoritm, the result .... There has been a lot of talk in the...
According to published reports | May 6, 2021 |

Why is BHP funding $2 Million into this Prospect Generator?

Riverside Resources (TSX.V: RRI | OTCQB: RVSDF ) In this exclusive interview, Dr. John-Mark Staude of Riverside Resources sits down with Maurice Jackson of Proven and Probable to discuss the strategic alliance with multi-billion...
Maurice Jackson | October 23, 2019 |

MagIndustries (T.MAA) up 12% on China funding news

Top Bullboards post: “Wow. I feel so sorry for those that have braved this nasty story . Myself included. I honestly thought this was it for all of you. I will disclose I have no interest in this company any longer and no I do not have any inside knowledge,&CloseCurlyQu...
Stockhouse Editorial | November 21, 2013 |

Surface Oncology Shares Trade Up 40% on Phase1 Study Plans for SRF617 Combined with Merck's KEYTRUDA

Shares of Surface Oncology set a new 52-week high price after the company reported that it is partnering with Merck & Co. in an immuno-oncology study of SRF617, targeting CD39 in combination with KEYTRUDA® (pembrolizumab) in solid tumor patients. Clinical-...
Streetwise Reports | May 21, 2020 |

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...
Streetwise Reports | December 3, 2019 |

The Surging AR Company Leading the Industry

3D AR ads are coming to the market faster than you might think. Omri Wallach of Stockhouse Media was recently joined live on the line by Evan Gappelberg, CEO of NexTech AR Solutions ( CSE:NTAR , OTC:NEXCF , Forum ), fresh off the Company's recent re...
Omri Wallach | November 4, 2019 |
1 2 3 4 5 6 7 8 9 10 ...